10 Tips for Publishing in ACS Journals
Thursday, February 9, 2023
Virtually with ACS Webinars
ACS Publications partners with authors to get their manuscript published. Join Editor-in-Chief Craig Lindsley of the Journal of Medicinal Chemistry and Editor-in-Chief Kelly Chibale of the ACS Medicinal Chemistry Letters as they provide you insider advice to make your manuscript clear, concise, and captivating so that you can improve your chances of getting publishing in an ACS Journal.
What you will learn:
- Ten scholarly publishing tips to write a successful manuscript and choose the most appropriate journal
- How to best understand the scope of a journal and its simplified submission requirements
- Real-life examples from submissions and some of the typical reasons for manuscript rejection
This ACS Webinar is moderated by Lori Ferrins of Northeastern and Becky Miller of ACS on Campus and is co-produced with ACS Webinars.
Registration now available on the ACS Webinars page.
10 Tips for Publishing in ACS Journals
- Craig Lindlsey, Ph.D., Editor in Chief, Journal of Medicinal Chemistry & Director, Warren Center for Neuroscience Drug Discovery (WCNDD) and University Distinguished Professor of Pharmacology, Chemistry & Biochemistry)
- Kelly Chibale, Ph.D., Editor in Chief, ACS Medicinal Chemistry Letters & Professor of Organic Chemistry, University of Cape Town, South Africa
- Becky Miller, Program Manager, ACS on Campus
Craig Lindsley, Ph.D.
EIC, Journal of Medicinal Chemistry
Director, Warren Center for Neuroscience Drug Discovery (WCNDD) and University Distinguished Professor of Pharmacology, Chemistry & Biochemistry)
Craig W. Lindsley, Ph.D. is the Director of the Warren Center for Neuroscience Drug Discovery (WCNDD) and University Distinguished Professor of Pharmacology, Chemistry & Biochemistry. Dr. Lindsley’s research is focused on the development of novel treatment strategies for schizophrenia, Alzheimer’s disease, Parkinson’s disease, Fragile X Syndrome and other brain disorders. In addition, his academic lab is focused on teaching the basic tenants of organic chemistry (synthetic methods, total synthesis, chemical biology) and then apply these skills to translational science problems. In 2009 Craig became the founding Editor-in-Chief of ACS Chemical Neuroscience, the interim EIC of ACS Pharmacology & Translational Science (2020) and the EIC of Journal of Medicinal Chemistry (2021- ). Recipient of major awards from ACS and ASPET, including induction into the ACS MEDI Hall of Fame (2021), and named a Fellow of the American Society for Pharmacology and Experimental Therapeutics, the Royal Society for Chemistry, the National Academy of Inventors and the American Association for the Advancement of Science.
Kelly Chibale, Ph.D.
EIC, ACS Medicinal Chemistry Letters
Professor of Organic Chemistry, University of Cape Town, South Africa
Kelly Chibale is a professor of organic chemistry at the University of Cape Town (UCT) where he holds the Neville Isdell Chair in African-centric Drug Discovery & Development. He is also a member of the UCT Institute of infectious disease & molecular medicine, founding Director of the South African medical research council drug discovery & development research unit at UCT and the Founder and Director of the UCT drug discovery and development centre, H3D, a Johnson and Johnson (J&J) Satellite Centre for Global Health Discovery. His research interest is in infectious disease drug discovery. Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK. This was followed by postdoctoral stints at the University of Liverpool in the UK and at the Scripps Research Institute in the USA. He was a Sandler Sabbatical Fellow at the University of California San Francisco, a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine, and a Visiting Professor at Pfizer. He is a recipient of many awards and honors, including being named by Fortune magazine as one of the World’s 50 Greatest Leaders in 2018. He previously served as an Associate Editor of Journal of Medicinal Chemistry.
Topic Editor, Journal of Medicinal Chemistry
Research Associate Professor, Neglected Diseases Laboratory
Dr. Lori Ferrins is a Research Associate Professor at Northeastern University. Her research focuses on the development of drugs for intractable diseases, including parasitic neglected tropical diseases, pathogenic free-living amoebae, and antifungal agents. Her research uses advanced models of infection to improve the translation of in vitro activity to in vivo efficacy, while also relying on the tenants of phenotypic and target driven optimization. Dr. Ferrins is also a Topic Editor for the Journal of Medicinal Chemistry and is passionate about promoting early career chemists.